Development of Allergenicity and Toxicity Assessment Methods for Evaluating Transgenic Sugarcane Overexpressing Sucrose–Phosphate Synthase

Abstract

Sugarcane is considered as an industrial crop that produces sugar. The number of transgenic sugarcane on the market is currently increasing. Therefore, investigation of the potential allergens and toxics in transgenic sugarcane is necessary, since there is less information regarding food safety for human consumption. Bioinformatics and experimental analysis were used for the validation of the allergenic potential of transgenic sugarcane overexpressing sucrose–phosphate synthase (SPS). Bioinformatics analysis showed that SPS has no homology with any known allergenic proteins. However, eight-residues identical contiguous sequence was detected, and further specific assessment is required to confirm the potential of allergenicity. The results of protein stability evaluation showed that SPS gradually decreased at 28 °C and rapidly inactivated at 60 °C and 90 °C by heat treatment. In addition, total protein was degraded by simulated gastric fluids (SGF), and simulated intestine fluid (SIF) assays for one-minute incubation. The level of specific IgE in the transgenic sugarcane and controls also showed no potential risk of allergy. An acute oral toxicity assay was performed by oral gavage of transgenic sugarcane juice in mice. The LD₅₀ for transgenic sugarcane juice was >25 gr/kg body weight. We propose a development method for allergenicity and toxicity assessment in transgenic sugarcane.

1. Introduction

In agricultural biotechnology, genetically engineered products have triggered a range of social and ethical concerns. The awareness of how biotechnology products will affect human life has been generated in order to protect consumers. The analysis of food safety should be based on scientific evidence and products should be assessed for eligibility for human consumption. According to the guidelines of the World Health Organizationn (WHO) and Food and Agriculture Organization (FAO) [1] in the Codex Alimentarius document, several risk assessments are essential to determine whether transgenic crops are safe or not. There are several reports evaluating transgenic crops, including allergenicity and toxicity analysis [2,3,4] since the substitution or insertion of genetic material has raised risks the issue in allergenicity.

The first step of allergenicity testing on transgenic crops is to identify potential allergens using bioinformatics methods. The amino acid sequences of target proteins expressed in transgenic products are compared with known allergenic proteins to search for sequence similarity or homology through computational studies [5,6]. To prove bioinformatics results, other allergenicity analysis has been carried out by certain experimental conditions, including digestion assay with heat treatment [3], in vitro gastric digestion [2,4], and evaluation of IgE [7,8]. A toxicity study, in parallel with an allergenicity assessment, has also been used to assess potential hazards to human through the acute exposure of genetically engineered products to animal model testing [4].

Sugarcane is a major crop that produces sugar in tropical regions, and transgenic sugarcane has been recently developed for drought stress tolerance [9,10], pest resistance [11,12], virus resistant [13,14], and increased crop yield by introducing a gene for sucrose–phosphate synthase (SPS; EC 2.4.1.14) (under review). Several tests for allergenicity and toxicity have to be evaluated in transgenic sugarcane overexpressing gene SPS, since there is no report for the evaluation in transgenic sugarcane. Although authentic SPS is expressed in sugarcane as well, overexpression of SPS will result in the modification of sucrose biosynthesis in sugarcane and this metabolism exchange must be analyzed.

In the present study, we modified the method that has been previously reported for allergenicity [3,8,15,16] and toxicity [17,18] assessments with biochemical and molecular approach in transgenic sugarcane, particularly transgenic sugarcane overexpressing SPS gene. The allergenicity analysis was primarily conducted by homology searching and comparison with any known protein allergens since the allergenic potential of SPS has not been clearly tested. Evaluation using in vitro methods assessing the degradation of protein in digestive fluids and thermal stability analysis were carried out by immunoblotting and enzymatic activity assays. Furthermore, in vivo testing, through the cross-reaction of transgenic proteins with the IgE response in rats, was performed by enzyme-linked immunosorbent assay (ELISA). Mice were used as a model to conduct acute oral toxicity testing because less test substance was required [19].

2. Materials and Methods

2.1. Plant Materials

Transgenic sugarcane (Saccharum officinarum L.) overexpressing the full-size SPS gene was developed by the Center for Development of Advanced Science and Technology (CDAST), University of Jember (Jember, Indonesia). The vegetatively propagated third generation of the transgenic and non-transgenic (wild type—WT) sugarcane cultivar Bululawang (BL) were grown in a greenhouse (biosafety containment) for 11 months. Four lines of transgenic sugarcane, SP1, SP2, SP3, and SP4, and WT sugarcane were cultivated in pots containing soil. At six months of age, transgenic sugarcanes were analyzed for in vitro assessments, while at approximately 11 months of age, the plants were harvested for in vivo evaluation such as allergenicity and toxicity assays. After harvesting and observation, the transgenic plants were destroyed.

To verify the transgenic sugarcanes, polymerase chain reaction (PCR) was performed on genomic DNA samples using a pair of primers generating a segment of the neomycin phosphotransferase gene (nptII) as the marker gene. The PCR product was electrophoresis on 1% gel agarose, stained with ethidium bromide and documented on GelDoc

2.2. Animals and Housing

Fourty BALB/c mice (4 weeks old, 20 males and 20 females) were used for the toxicity assessment, and 12 male Wistar rats (4 weeks old) were used for analysis of allergenicity [20]. The animals were obtained and purchased from the Laboratory of Animal Physiology, Maulana Malik Ibrahim State Islamic University (Malang, Indonesia). All animals were housed at CDAST, University of Jember (Jember, Indonesia) and maintained under the same conditions with a temperature of 23 to 25 °C, 45% to 55% relative humidity, and a photoperiod of 12 h light/12 h dark [21,22]. Following one week of acclimatization, the animals were divided into the two treatment groups. All procedures involving animal treatments were approved by the Ethics Committee of Faculty Medicine, University of Jember (Jember, Indonesia) in November 2017.

2.3. Allergenicity Assessment

2.3.1. Bioinformatics Analysis

The first evaluation in the allergenicity assessment was to compare the amino acid sequence of SPS with those of allergenic proteins. Based on bioinformatics analysis, the potential allergenicity of the SPS protein can be identified via similarity to any known allergens. The sequence of SPS gene (SoSPS1; gene accession number AB001337 in the GenBank) was obtained from the National Center for Biotechnology Information (NCBI) database [23,24] and further aligned for allergenic potency using AllergenOnline (database http://www.allergenonline.com, version 18B) [3,4,25].

2.3.2. Heat Stability Treatment

The SPS protein of transgenic sugarcane was prepared for evaluation of its susceptibility to thermal treatment. Three grams of the transgenic sugarcane leaf was pulverized with liquid N₂, and the frozen leaf powder was continouesly ground in three volumes of an extraction buffer [50 mM MOPs (pH 7.5), 10 mM MgCl2, 1 mM EDTA, 2.5 mM DTT, 1 µL PMSF, and 10% PVPP]. The insoluble fraction was removed by centrifugation at 14,000 rpm (Hitachi CR21GIII, Tokyo, Japan) and a temperature of 4 °C for 10 min. The soluble protein was subjected to PEG-6000 fractionation between 6% and 12%, according to a previous method with appropriate modification [24]. The fractioned protein was diluted in 1 mL buffer containing 50 mM MOPs (pH 7.5), 10 mM MgCl₂, 1 mM EDTA, and 2.5 mM DTT. The protein content was further measured by the Bradford method [26], and used for a heat stability assessment.

Approximately 0.1 mL of the soluble protein, with a concentration of 8.5 μg/μL, was exposed to various temperature treatments of 28 °C, 60 °C, and 90 °C for intervals of 0, 5, 10, and 30 min incubations. At the time interval, 30 µL of the soluble proteins were taken and the heating treatments were stopped by immersion of the sample tube in ice. The treated sample was further analyzed for SPS enzymatic activity using spectrophotometer and expressed as µg sucrose/minute/µg protein. The proteins profile was monitored by immunoblotting using the specific polyclonal antibody against SPS [24].

2.3.3. In Vitro Simulated Gastric Fluids (SGF) and Simulated Intestine Fluid (SIF) Assays

The protein samples were prepared by the method described previously in the preparation for the heat stability assay. For these assays, 100 μL of the resulting crude SPS protein was assayed for simulated gastric fluid (SGF) containing 0.32% (w/v) pepsin (Nacalai tesque, Kyoto, Japan) and 34 mM NaCl at pH 1.2 [15], and simulated intestinal fluid (SIF) containing 10 mg/mL trypsin (Nacalai tesque, Kyoto, Japan) in 50 mM KH₂PO₄ at pH 7.5 [27]. Before assay, the SGF or SIF mixtures were pre-incubated at 37 °C for 3 min without the presence of crude SPS protein. The crude SPS protein was added with an equal volume of SGF or SIF (1:1 ratio), and the reaction mixture was subsequently incubated at 37 °C for periods of 0, 1, 3, 5, 10, and 30 min. The assay was performed in duplicate for each condition. The reaction mixtures of SGF and SIF were terminated by the addition of 200 mM Na₂CO₃ and heating at 100 °C for 3 min. The changing of SPS activity levels in the SGF and SIF treatments were monitored by enzymatic activity measurement and sodium dodecyl sulfate polyacrylamide-gel electrophoresis (SDS-PAGE, 10%) [28], followed by CBB-staining, immunoblotting analysis.

2.3.4. In Vivo Allergenicity Assay in Rats and Measurement of the Protein-Specific IgE Antibody

The 11-month-old harvested sugarcane stem was ground and squeezed to collect the juice from internodes number 3 to 8 of the transgenic (SP1) and non-transgenic (WT) sugarcane. The sugarcane juice was kept at −80 °C for further allergenicity testing in rats. An 18-gauge stainless steel animal feeding needle was utilized for oral gavage [16] with sugarcane juice doses at 8 g/kg of body weight per day. Positive control rats were sensitized with Ovalbumin (OVA; Pharmacia, Uppsala, Sweden) weekly for 14 days, while negative control rats were not treated with either sugarcane juice or OVA. Sensitization of OVA to rats was performed through subcutaneous injection of 1 mg OVA in 1 mL solution containing 0.9% NaCl with 3.5 mg aluminum hydroxide (Sigma Aldrich, St. Louis Missouri, MO, USA) [29].

Blood samples were taken by retro-orbital plexus on days 0, 7, and 14, and sera were obtained by centrifugation of the coagulated blood samples at 5000 rpm and 4 °C for 15 min. The coagulation process was conducted through incubation of the blood samples at room temperature for 2 h, and the sera was further stored at −80 °C until use. Detection of IgE in each serum sample was performed using a rat IgE ELISA kit (Immunology Consultants Laboratory, Inc., Portland, OR, USA) according to the manufacturer’s instructions. ELISA analysis was performed to detect the specificity of IgE binding, and to compare the allergenicity between transgenic sugarcane and controls. The IgE proteins were visualized using 3,3′,5,5′-tetramethybenzidine (TMB) and hydrogen peroxide as the substrate of horseradish peroxidase-conjugated goat anti-rat IgE for color development. The developed color was measured at an absorbance of 450 nm using a microtiter plate reader (SH-1000, Corona Electric Co., Ltd., Tokyo, Japan).

2.4. Acute Oral Toxicity Assessment

To evaluate the toxicity of transgenic sugarcane, the sugarcane juice was prepared using a method mentioned in the previous section of allergenicity test. The 40 mice were divided randomly into 4 groups, each group consisted of 10 mice with 5 males and 5 females. The groups were treated according to the sugarcane juice dosage induction; group I is injected at a dose of 0 g/kg body weight as a negative control, group II is 6.25 g/kg body weight, group III is 12.5 g/kg body weight, and group IV is 25 g/kg body weight, which is equal to sucrose concentration of 0, 0.94, 1.88, 3.76 g/body weight, respectively. The sucrose contents were determined according to the assumptions of 15% sucrose content in sugarcane juice [30]. To substitute the sugarcane juice injection at group I, the mice were administered by oral gavage of 0.5% CMC-Na suspension according to a method previously described [31]. The mice were not fed for 12 h before treatment induction [21,31]. All mice were observed for signs of toxicity (piloerection, motor activity, vocal tremor, and feces) during 4 h after treatments and daily for 14 days. The weight of the mice was also recorded daily for 14 days of observation [17,18]. On day 14, the mice were sacrificed via cervical dislocation and dissected to examine the morphological condition of vital organs including the liver, spleen, kidneys, and heart.

2.5. Statistical Analysis

Statistical analysis was carried out using the statistical software Statistical Product and Service Solutions (SPSS) version 22 (SPSS Inc., Chicago, IL, USA), and the results were considered as significant differences when p < 0.05. The statistical analysis was calculated to differentiate the allergenicity and toxicity assessments in response to non-transgenic and transgenic sugarcane consumption.

3. Results and Discussion

3.1. Bioinformatics Assessment of the Protein SPS Expressed in Transgenic Sugarcane

Bioinformatics analysis was carried out to determine potential allergen and cross-reactivity between SPS and any known allergen proteins. The possibility of cross-reactivity in transgenic crops can be examined by multiple characteristics of sequence comparisons to known allergens. A match alignment of >35% identity, over a segment of 80 amino acids, and a contiguous identical match of eight amino acids have been reported to indicate potential cross-reactivity [32,33]

The full-size protein sequence encoded by the SoSPS1 gene (Figure S1A) was subjected to bioinformatics tools through the FASTA search of AllergenOnline (http://www.allergenonline.org, version 18B), and the sequence comparison of SoSPS1 to allergens was performed. The results demonstrated no more than 35% shared identity over ≥80 amino acids segments (Figure S1B). Thus, sugarcane SPS is not potentially allergenic since there was no similarity with allergenic proteins in the database.

A search for eight identical contiguous amino acid sequences was also conducted, and a sequence match was detected at the N-terminal region of sugarcane SPS with a shared eight-mer (GGGGGGGG). The obtained result from AllergenOnline showed homology to a chitinase from Zea mays L. (

Table 1. Sequence homology of selected sequences using contiguous identical matching of eight amino acids in AllergenOnline, version 18B.

Allergen	Species	Description	Sequence in FARRP *	Sequence Length	Matching Region of Contiguous Amino Acids
Chitinase	Zea mays L.	Food allergen	GI:260401081	279	62-GGGGGGGG-69
Endochitinase A	Zea mays L.	Food allergen	GI:116329	281	61-GGGGGGGG-68

* Food Allergy Research and Resource Program (FARRP).

). These eight-residue identical contiguous sequences of sugarcane SPS share conserved homology residues with other C4 plants SPSs, such as sorghum SPS (gene Accession number EES04111.1 in GenBank) and Zea mays L. SPS (gene accession number P31927.1 in GenBank). Nevertheless, the eight-glycine contiguous sequence of sugarcane SPS has not been shown in C3 plants, such as spinach SPS (gene accession number AAC60545.2 in GenBank) and potato SPS (gene accession number CAA51872.1 in GenBank). Accordingly, the results suggested that the 8-residue contiguous sequence of sugarcane SPS is merely representative characteristic of SPS sequence in C4 plants, and it might be no tendency to allergenicity. Moreover, there is no reports that describe the GGGGGGGG segment acts as an epitope in allergenic reaction.

It is noteworthy that the use of 6 to 8 identical amino acids in allergenicity detection is considered contradictory. Previous studies have reported that comparison of 6 to 8 amino acids might yield a false–positive predictive value [3,34,35]. There is no sufficient evidence that a short peptide match reveals clinical cross-reactivity [35,36]. Therefore, Codex has been recommended as a way to identify 80-amino-acid sequence matches with a known allergen [5,32,34]. However, several regulatory authorities require the evaluation of eight-amino-acid identity matches with allergens [37]. Consequently, scientifically validated testing with specific assessments is required to confirm the allergenicity of overexpressed SoSPS1 in sugarcane. Evaluation of serum IgE testing and in vitro digestibility have been recommended by the Codex Alimentarius Commission guidelines as a further step in allergenicity assessment [5,34,37].

3.2. Thermal Stability Assessment

Transgenic sugarcane has been previously confirmed by PCR DNA amplification to yield a 550-bp fragment of the nptII gene, and the transgenic plants were designated SP1, SP2, SP3, and SP4 (Figure S2). An extracted protein sample from transgenic sugarcane was prepared for heat stability testing, the protein profile was determined by Western blot analysis (Figure 1A) and monitored with an enzymatic activity assay (Figure 1B). The SPS protein at time zero in the control sample was clearly detected with the major band at 120 kDa by Western blot analysis. When the samples were treated at 28 °C, 60 °C, and 90 °C for up to 10 min, the major band of the SPS protein (120 kDa) was still detected (Figure 1A). However, the SPS activity assay result showed a gradual decrease during the time-course of incubation despite the fact that the protein remained detectable. The activity of SPS was reduced after 5 min of incubation at room temperature (28 °C), while the enzyme was inactivated thoroughly by incubating the enzyme at 60 °C and 90 °C for 5 min (Figure 1B).

Transgenic crops may contain new expressed proteins that require safety assessment procedures to evaluate protein stability [38]. Proteins with high stability in elevated temperature are generally associated with allergenic potential [3,39]. Identification of potential protein hazards can be conducted by examining physical properties through a heating stability assessment [38]. We assume that SPS protein was susceptible to heat treatment [40]. In fact, SPS protein was still detected at the highest temperature (90 °C) of incubation (Figure 1A). The additional test of enzymatic activity analysis under heat treatment is required to prove the protein stability and function of SPS. The enzymatic activity of SPS showed that the activity of SPS gradually declined at the temperature of 28 °C and completely lost at 60 °C and 90 °C for 5 min incubation. The loss of enzymatic activity suggested that SPSs might be denatured and lose their function. In order to verify the protein stability assessment, the enzyme activity measurement was conducted to consider and interpret potential allergenicity.

A similar result was obtained in the safety assessment for transgenic plant-expressed phosphinothricin acetyltransferase (PAT). Although no protein degradation was shown on SDS-PAGE after heat treatment at 90 °C, the PAT protein was completely inactivated [41,42]. The results of PAT protein analysis corroborated our heat stability results. By analogy, it revealed that SPS lost its catalytic functionality under denaturing conditions and had no potential to become an allergen.

3.3. In Vitro Simulated Gastric Fluids (SGF) and Simulated Intestine Fluid (SIF) Assessment

The SGF and SIF models provide allergenic potential evaluation methods, since food proteins are rapidly digested by gastric and intestinal processes [3,43]. The combined results of CBB-stained SDS-PAGE gels and Western blotting showed that transgenic sugarcane protein, at time zero as a control sample, underwent no significant degradation changes in the absence of pepsin and trypsin (Figure 2A,B, upper and middle).

However, as shown by the CBB protein staining, almost all of the crude protein in the transgenic sugarcane exhibited changes in the digestion pattern over a few minutes of incubation, and was thoroughly digested during the duration of the 30 min treatment (Figure 2A,B, upper). The crude proteins were gradually degraded within 0.25 to 0.5 min through treatment with pepsin and trypsin and remarkably lost after 1 min of incubation. Moreover, the major protein bands that consisted of C4 plant endogenous PEP carboxylase and the large subunit of Rubisco, with molecular masses of approximately 100 kDa and 53 kDa, respectively, were susceptible to degradation in the SGF and SIF assessments.

Western blot analysis showed that the SPS protein was completely digested in 1 min by SGF and SIF assessments (Figure 2A,B, middle). The result of the activity assay was also in good agreement with the protein profiles from Western blot analysis. The loss of enzymatic activity was shown after 1 min incubation of the digestive enzymes, that indicated the SPS activity is rapidly inactivated (Figure 2A,B, lower). Collectively, the results showed that SPS and other proteins in transgenic sugarcane can be degraded by the enzymatic digestion system.

Proteins that are rapidly degraded into small peptides and amino acids can be considered less allergenic since the protein is not able to resist the acidic conditions of the digestive system [3,39]. Regarding the in vitro digestibility, our result has good relevance in regard to the efficiency of enzymatic digestion in the stomach and intestine.

3.4. In Vivo Allergenicity Assay in Rats and Measurement of the Protein-Specific IgE Antibody

Typical allergy symptoms are usually triggered by the production of immunoglobulin E (IgE) [32,44]. In this work, rats were used as an animal model to examine the accumulation of IgE [16,45] after sensitization to non-transgenic and transgenic sugarcane juice. The treatment was devided into four groups, with three replicates in each group. The treatment group consists of C− is not subjected to any treatment as a negative control, WT is subjected to non-transgenic sugarcane juice, SP is subjected to transgenic sugarcane juice, and C+ is OVA sensitization as a positive control.

The specific-IgE levels in sera between the non-transgenic and transgenic sugarcane groups were compared to interpret the potential allergenicity of the transgenic crops. The antibody titers at day 7 and day 14 were observed to evaluate the accumulation of IgE in sera. The production of antibodies at day 7 was lower in titer and appeared similar among samples from the C−, WT, SP, and C+ groups (Figure 3). Statistical analysis showed that there is no significant difference (p > 0.05) between the C−, WT, SP, and C+ samples at day 7. Synthesis of allergen-specific IgE generally occurred at approximately 7 days, and the peak of the IgE titer was produced during days 10 to 14; thus, a booster injection was required to stimulate increased levels of IgE [45,46]. Continuous ingestion of OVA showed a significant increase in the IgE level at day 14, which was higher by almost four-fold than IgE production at day 7 (Figure 3). Statistical analysis showed a significant difference (p < 0.05) between rats fed OVA and those fed transgenic sugarcane juice. However, the IgE titers of C− and SP samples at day 14 were shown to be comparable with the IgE titers at day 7. Moreover, the declined antibody titers of the WT group samples at day 14 suggested the degradation of antigens. Based on the animal model experiments, the results of the specific-IgE assessment indicated that transgenic sugarcane juice has no potential to be allergenic.

3.5. Acute Oral Toxicity Assessment

The acute oral toxicity was assessed as described in the general principles of Guidelines for the Testing of Chemicals by Organization for Economic Co-operation and Development (OECD) guideline 420 with appropriate modification [3]. The toxicity assessment showed that the mice appeared healthy throughout the treatments until sacrifice on day 14. The signs of toxicity such as piloerection, motor activity, vocal tremor, and feces were not observed during observation.

The toxicity study showed that animal death was not occured at any of sugarcane juice dose treatments (6.25, 12.5, and 25 gr/kg of body weight) (

Table 2. Acute toxicity study in mice.

			Death of Animals
Group Treatment	Sample Treatment	Dosage (gr/kg)	After 72 h	After 14 Days	Percentage (%) *
I	Control	0	0	0	0
II	Sugarcane Juice	6.25	0	0	0
II	Sugarcane Juice	12.5	0	0	0
IV	Sugarcane Juice	25	0	0	0

* The mortality percentage in mice (n = 10/group); Death of animals after 14 days was zero percent, thus the Lethal Dose 50 (LD₅₀) > 25 gr/kg.

). In addition, similar results were also observed in the control mice administered with 0.5% of CMC-Na solution. These results revealed that transgenic sugarcane is considered non-toxic since the mortality rates remained zero after treatment with the highest tested dose of sugarcane juice at 25 gr/kg body weight.

The body weight of mice was measured daily for 14 days, and the recorded data was plotted on a graph (Figure 4). The result showed that there were slight gains in body weight at the doses of 6.25, 12.5, and 25 gr/kg body weight. The body weight gain was a reflection of the normal pattern of body weight growth, since a similar growth pattern was observed in the mice treated with the control CMC-Na solution. Statistical analysis showed that there was no significant difference (p > 0.05) in regard to the gain in body weight between sugarcane juice treatments and the control. Thus, all treated mice had similar body weight in both groups during 14 days of observation.

To confirm the results from the toxicity assessment of sugarcane juice, the internal vital organs of the mice were dissected after sacrifice at day 14 and the wet weight was recorded. The wet weights of the organs showed no significant differences (p > 0.05) between the sugarcane juice and control treatments. The relative organs wet weight of heart, liver, spleen, and kidneys were also similar and not affected by sugarcane juice treatments (

Table 3. Mice organ weight measurements for acute toxicity analysis.

	Dosage of Sugarcane Juice
Organs	0 gr/kg	6.25 gr/kg	12.5 gr/kg	25 gr/kg
Heart	0.37 ± 0.03	0.44 ± 0.03	0.41 ± 0.03	0.44 ± 0.04
Liver	5.74 ± 0.68	6.25 ± 0.19	7.06 ± 0.07	6.80 ± 0.10
Spleen	0.77 ± 0.17	0.79 ± 0.06	0.85 ± 0.02	0.84 ± 0.11
Kidneys	1.31 ± 0.10	1.56 ± 0.03	1.29 ± 0.07	1.43 ± 0.12

The weight values are the mean ± SEM (n = 5/group), with the mean of weight being wet organ (gr)/body weight (gr). The statistical result was p > 0.05 (one-way ANOVA) for transgenic sugarcane juice treatment compared to the control.

). In addition, macroscopic observation showed no changes in the organs. However, the microscopic observation was not conducted since the mice showed no abnormal tendency. These results imply that transgenic sugarcane juice has no toxicity effect in the mice. According to OECD guidelines, additional testing is not required since there was no mice death recorded in the toxicity assessment.

3.6. A Model for Food Safety Assessment of Transgenic Sugarcane

The allergenicity evaluation consists of three steps: Bioinformatics analysis, in vitro thermal testing and digestive stability assessments, and in vivo IgE analysis in rats. These assessments were conducted according to the guidelines of the Codex Alimentarius Commission. Furthermore, toxicity testing was conducted by acute oral toxicity assays in mice with a procedure adopted from the OECD. Moreover, it has been documented that sugarcane has not been associated with an allergenic response, as there have been no reports regarding food-related allergic reactions to sugarcane [47]. Thus, we propose a model for the risk assessment framework in transgenic sugarcane as shown in Figure 5.

4. Conclusions

In this study, bioinformatics analysis showed no sequence homology with any allergens in segments over 80 amino acids in length. The SPS protein was rapidly degraded by the enzymatic digestive system and inactivated by heating treatment. There was also low production of IgE after sensitization to transgenic sugarcane. Additionally, no mortality occurred after treatment with the highest dose of 25 g/kg juice of transgenic sugarcane. These results prove that the overexpressed SPS gene in transgenic sugarcane does not possess characteristics associated with allergens and is not toxic. Biochemical and molecular analysis provide new insight regarding the potential allergenicity and toxicity of transgenic sugarcane as well as other transgenic crops.